Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 12/20 | 0.65 |
| ▸ | NPC1 | O15118 | 11/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.65 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 4/20 | 0.54 |
| ▸ | PKM | P14618 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 7/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 2/20 | 0.53 |
| ▸ | GUSB | P08236 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10553462 | 0.90 | KDM4E (0.59) | RAB9ANPC1SMN1; SMN2TP53PKM | |
| SCHEMBL27845508 | 0.89 | NPC1 (0.67) | RAB9ANPC1SMN1; SMN2ATAD2TP53 | |
| SCHEMBL29244073 | 0.88 | SMN1; SMN2 (0.58) | RAB9ANPC1SMN1; SMN2ATAD2TP53 | |
| SCHEMBL15272148 | 0.86 | RAB9A (0.57) | RAB9ANPC1SMN1; SMN2TP53PKM | |
| SCHEMBL21251531 | 0.86 | NPC1 (0.66) | RAB9ANPC1SMN1; SMN2TP53PKM | |
| SCHEMBL13134532 | 0.83 | RAB9A (0.53) | RAB9ANPC1SMN1; SMN2ATAD2TP53 | |
| SCHEMBL2197485 | 0.82 | SMN1; SMN2 (0.60) | RAB9ANPC1SMN1; SMN2ATAD2TP53 | |
| SCHEMBL14395153 | 0.82 | HPGD (0.69) | RAB9ANPC1SMN1; SMN2TP53PKM | |
| SCHEMBL12419577 | 0.82 | GUSB (0.48) | RAB9ANPC1SMN1; SMN2ATAD2TP53 | |
| SCHEMBL22734893 | 0.82 | RAB9A (0.54) | RAB9ANPC1SMN1; SMN2ATAD2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10749128-B2 | Depositable ion organic function material and use thereof in organic electroluminescent device | KUNSHAN GO-VISIONOX OPTO-ELECTRONICS CO., LTD. (CN) | 2020-08-18 | — | — | US | disclosed |
| EP-3318617-B1 | DEPOSITABLE ION ORGANIC FUNCTION MATERIAL AND USE THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE | KUNSHAN GOVISIONOX OPTOELECTRONICS CO LTD (CN) | 2019-08-14 | — | — | EP | disclosed |
| US-20040248950-A1 | Apo ai expression accelerating agent | SHIONOGI & CO., LTD. (JP) | 2004-12-09 | — | — | US | disclosed |
| EP-1419770-A1 | APO AI EXPRESSION ACCELERATING AGENT | SHIONOGI & CO., LTD. (JP) | 2004-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040248950-A1 | Apo ai expression accelerating agent | APOB, APOL1, NR1H2 | RAB9A 3759/4885NPC1 129/4885SMN1; SMN2 1789/4885 |
| US-10749128-B2 | Depositable ion organic function material and use thereof in organic electroluminescent device | OCIAD1, OCIAD2, OXA1L | RAB9A 2721/4885NPC1 905/4885SMN1; SMN2 2962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.